Neuroprotective and neurotrophic actions of glucagon-like peptide-1: An emerging opportunity to treat neurodegenerative and cerebrovascular disorders
Most of the clinical evidence points to GLP-1RAs as having no discernible effect on BMD or fracture rates, indicating that they have a neutral effect on bone health
The first is an over-the-counter supplement marketed to support the bodys natural GLP-1 production
This full sensation helps deter users from overeating resulting in weight loss
John Batsis, geriatra de la Facultad de Medicina de la Universidad de Carolina del Norte que estudia los medicamentos GLP-1 en adultos mayores
While medication alone wont solve this global health crisis, GLP-1 therapies can help millions overcome obesity and reduce its associated harms. The WHO did qualify its recommendations, saying endorsement is conditional due to limited data on their long-term efficacy and safety, maintenance and discontinuation, their current costs, inadequate health-system preparedness, and potential equity implications. The drugs should not be used by pregnant women, and should be paired with evidence-based interventions like healthy diets and physical activity, the guidelines also stress